{
  "id": 11262906,
  "title": "Cronus Pharma Announces the Launch of Florfinasone™ Otic for the Treatment of Otitis Externa in Dogs",
  "url": "https://urgent.news/2026/10/01/cronus-pharma-announces-the-launch-of-florfinasonetm-otic-for-the",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-01T19:11:09.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/cronus-pharma-announces-the-launch-of-florfinasone-otic-for-the-treatment-of-otitis-externa-in-dogs"
  },
  "original_language": "en",
  "account": null,
  "summary": "EAST BRUNSWICK, N.J. — Cronus Pharma LLC, a fully integrated animal health company, today announced the launch of Florfinasone Otic (florfenicol, terbinafine, mometasone furoate), an FDA-approved product indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius). Florfinasone Otic is…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}